glp-1 agonist drugs oral Orforglipron (Foundayo) – A Second Receptor for Weight Loss 🔗 Link in bio FDA approves Foundayo, an oral

It is available as a research-grade 5mg peptide for laboratory use

It does not prove that every detected signal was the intact nine-residue peptide

The 50mg dosage guide provides specific protocols optimized for smaller vials

While the vote is only advisory and must still go through a formal rulemaking process, it could give patients the mistaken impression that these unapproved peptides are FDA-endorsed and accelerate their use through compounding pharmacies

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2)

By contrast, the fluorescence of PNT PSs is barely detectable in normal tissue at 12 h, likely due to their rapid biodegradation